2m 2m 2m 2m 2m 2m 2m
ORGANGNSS HLDG-A (ORGO)
NASDAQ
$2.38+$0.005 (+0.21%)
Price as of Aug 03, 2026 11:32 AM EDT- $305.0MMarket Cap
- -47.45%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ORGANGNSS HLDG-A (ORGO)
$2.38+$0.005 (+0.21%)
ORGO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.37 | ||
Change | -$0.08 (-3.27%) | ||
Open | $2.48 | ||
High | $2.48 | ||
Low | $2.29 | ||
Previous Close | $2.45 | ||
Volume | 1,058,063 | ||
30-Day Average Volume | 708,020 | ||
1-Week Change | -0.84% | ||
1-Month Change | -2.47% | ||
1-Year Change | -47.45% | ||
3-Year Change | -44.50% | ||
5-Year Change | -84.55% | ||
Fundamentals | |||
Shares Outstanding | 128.7M | ||
Total Assets | $520.0M | ||
Market Cap | $305.0M | ||
Enterprise Value | $263.6M | ||
Period: QTR TTM FY | |||
Revenue | $36.3M | ||
Net Income | -$53.2M | ||
Free Cash Flow | $18.0M | ||
EBIT | -$68.5M | ||
EBITDA | -$62.8M | ||
Net Working Capital | $192.5M | ||
EPS | -$0.44 | ||
Enterprise Value/EBITDA | -4 | ||
Enterprise Value/Revenue | 7 | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | 17 | ||
Price/Operating Cash Flow | 14 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue